Table 2.
Prognostic factors
Prognostic factor | Variables that influence overall survival | Variables that influence progression-free survival |
---|---|---|
Sex | 39 | 35 |
Preoperative treatment of liver | 15 | |
Metastatic situation: synchronous/metachronous | 17, 23, 27, 34, 38 | 44 |
Primary site and histological subtype | 15–26, 33, 34, 37–41, 43 | 31, 35 |
Symptomatic at the time of resection | 41a | |
Hepatic involvement | 25, 26 | |
Type of the intervention performed | 17, 37, 39–41 | |
Macroscopically incomplete resection (R2) | 17, 19, 38, 40 | 29 |
Surgical margin status | 16, 17, 19, 32, 34, 37, 38, 40, 42 | 35 |
Adjuvant treatment | 15, 17, 18, 20, 21, 24–26, 37 | 44 |
Presence of extrahepatic disease | 15, 16, 20, 27, 28, 30, 37 | |
Surgery timing | 19, 22, 26, 31 | 31 |
Postoperative complications | 17, 44 | 44 |
Number of metastases | 17, 19, 26, 27, 33, 39, 44 | 44 |
Size of metastases | 26, 29, 36, 41, 42 | 29, 44 |
Presence of vascular invasion | 36 | |
Lymph node metastases | 29, 36, 39 | 29 |
Disease-free survival | 26, 30, 37, 38, 41 | 17, 31, 35, 44 |
Blood transfusion | 44 | 44 |
aSymptoms within 1 year